J Manag Care Pharm / Gilead Sciences / Prime Therapeutics LLC / Award Rx Innovation Award Recipient Prime Therapeutics LLC / Janssen Pharmaceuticals / /
Country
United States / /
Currency
USD / /
Event
FDA Phase / /
Facility
Prime Therapeutics Specialty Pharmacy / Prime Specialty Pharmacy / /
IndustryTerm
early warning tool / media channels / conducted media / care management / social media / account management / side effect management / HCV treatment / utilization management / communications strategy / insurance specialists / finance / proactive communications approach / communications strategies / improved communications / /
MedicalCondition
chronic HCV virus infection / disease / idiopathic pulmonary fibrosis / liver failure / plaque psoriasis / hepatitis C / HCV / HCV infection / Virus Infection / Expanded hepatitis C / infection / chronic infection / breast cancer / chronic hepatitis C / /
MedicalTreatment
drug prescriptions / retreatment / drug therapy / /
Organization
P&T committee / FDA / Managed Care Organization / U.S. Centers for Disease Control and Prevention / /
Person
Ann Hepatol / /
Position
board member / CEO / pharmacy benefit manager / /
Product
Harvoni / PAs / HCV prescriptions / HCV drug / Gilead’s newest HCV drug / /
R x Innovation Award Rx Innovation Award Recipient Prime Therapeutics LLC Creation of “Specialty Drug Watch List” Successfully Manages Blockbusters Title: